Is KalVista Pharmaceuticals, Inc. (KALV) a Buy, Sell, or Hold?
NASDAQ : KALV
KalVista Pharmaceuticals, Inc. — Competitors
$27 USD
$0 (0.0%)
- Volume
- 4.26M
- Average Volume
- 3.54M
- Market Capitalization
- $1.44B
- P/E Ratio
- -8.36
- Dividend Yield
- 0.00%
- Price Target
- $27.00
- Year High
- $27.00
- Year Low
- $9.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.58
KALV vs. The Competition
| Properties | KALV | ADCT | BCYC | FDMT |
|---|---|---|---|---|
| Market Cap | $1.44B | $133.55M | $267.86M | $532.17M |
| Shares Outstanding | $53.24M | $127.19M | $69.39M | $52.28M |
| P/E Ratio | -8.36 | -1.0 | -1.41 | -3.83 |
| EPS | -2.74 | -0.89 | -2.73 | -2.36 |
| Day Low | 26.98 | 1.045 | 3.8 | 9.84 |
| Day High | 27 | 1.12 | 4.01 | 10.65 |
| Year Low | 9.83 | 0.78 | 3.8 | 5.11 |
| Year High | 27 | 4.98 | 9.159 | 14 |
| Average Price 50 | 24.4316 | 1.59468 | 4.2008 | 10.469 |
| Average Price 200 | 17.0935 | 3.34492 | 5.6059 | 9.768 |
| Volume | 4.26M | 617.57K | 328.91K | 698.81K |
| Average Volume | - | - | - | - |